跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
立普妥 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Atorvastatin Calcium Tablets
Approved
化学药品
Atorvastatin Calcium Tablets
Upjohn Manufacturing Ireland Unlimited Company
🇨🇳 National Medical Products Administration
Approval Date
Mar 24, 2022
Approval ID
8FWSEbZ1VzC
Company
Upjohn Manufacturing Ireland Unlimited Company
Type
化学药品
Approval Details
Approval Id
8FWSEbZ1VzC
Approval Number
国药准字HJ20170216
Generic Name
阿托伐他汀钙片
Generic Name En
Atorvastatin Calcium Tablets
Trade Name
立普妥
Drug Type
化学药品
Dosage Form
片剂
Strength
20mg(以C₃₃H₃₅FN₂O₅计)
Reg Date
2022-03-24
Expired Date
2027-03-23
Company Name
Upjohn Manufacturing Ireland Unlimited Company
Production Company Name
Viatris Pharmaceuticals LLC
Company Detail Path
/organization/upjohn-manufacturing-ireland-unlimited-company
Production Company Detail Path
/organization/viatris-pharmaceuticals-llc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Mar 24, 2022
Approval ID
8FWSEbZ1VzC
Type
化学药品
Back to NMPA Approvals